Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oligonucleotide therapy for Leber Congenital Amaurosis

Oligonucleotide therapy for Leber Congenital Amaurosis

US Patent 10889817 · Granted Jan 12, 2021

Estimated economic value: $3,819,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligonucleotide therapy for Leber congenital amaurosis2024
Oligonucleotide therapy for Leber congenital amaurosis2024
Antisense oligonucleotides for the treatment of eye disease2022
Oligonucleotides to treat eye disease2021
Oligonucleotides to treat eye disease2020
Antisense oligonucleotides for the treatment of eye disease2020
Oligonucleotide therapy for leber congenital amaurosis2019
Oligonucleotide therapy for leber congenital amaurosis2019